Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Hempdoc


C.COOL

RE:RE:RE:RE:RE:RE:News .095 PP

Nickel77 wrote: Scorpion34 Looking quickly on the Internet it basically...

June 6, 2020

V.TLT

RE:RE:RE:RE:RE:RE:Breakthrough Therapy Designation

Eoganacht wrote: The first 3 patients in phase 1 were CR at 3 months even...

June 5, 2020

V.TLT

RE:RE:RE:Breakthrough Therapy Designation

Based on our type of ACT & Ph 1 results, I think a high 3 month CR rate (...

June 5, 2020

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Critical Shortage of BCG and Adverse Reactions to Treatment

enriquesuave wrote: It could be in case of undiagnosed  micro metastasis...

June 4, 2020

V.TLT

RE:RE:RE:RE:RE:RE:RE:Critical Shortage of BCG and Adverse Reactions to Treatment

greaterfoolFred wrote: "those patients who did not attain a CR post...

June 4, 2020

V.TLT

RE:RE:RE:RE:RE:Critical Shortage of BCG and Adverse Reactions to Treatment

vestor111 wrote: Interesting H-doc thanks for the insights.  With the...

June 4, 2020

V.TLT

RE:Breakthrough Therapy Designation

nemo3 wrote: From TLT's last press release, TLT needs to enroll and treat...

June 4, 2020

C.COOL

RE:RE:RE:News Flow?

Hi Nickel...cheers & very well said. After this latest NR, I am...

June 4, 2020

V.TLT

RE:RE:RE:Critical Shortage of BCG and Adverse Reactions to Treatment

greaterfoolFred wrote: When we get approval docs will offer this off-label...

June 3, 2020

V.TLT

RE:RE:May 29-31, 2020 Virtual ASCO Meeting

Yajne wrote: and importantly Adverse Effects in almost 84% of patients with...

May 31, 2020

V.TLT

May 29-31, 2020 Virtual ASCO Meeting

Ph 2 BCG-unresponsive NMIBC results for Atezolizumab....not too impressive...

May 31, 2020

V.TLT

RE:RE:Lancet 'study' not holding up to scrutiny

Hempdoc wrote: Quattro74 wrote: Scientists from arround the world, in...

May 30, 2020

V.TLT

RE:Lancet 'study' not holding up to scrutiny

Quattro74 wrote: Scientists from arround the world, in cluding statisticians,...

May 30, 2020

C.COOL

RE:New Appointment

helpline88 wrote: We welcome Mr Shacker to Core One Labs. Most of us will...

May 30, 2020

C.COOL

RE:Brad is up to no good again in my opinion!

Nickel77 wrote: This is refreshing: Bob Blink, CEO of TransCanna...

May 29, 2020

V.TLT

RE:Monday Trial Restart

Agree with you Macer...that's a good call.  I think June will be a...

May 29, 2020

V.TLT

RE:RE:DR.RAUOLT HAMMERS “trojan horse” DR. FAUCI

enriquesuave wrote: Large Lancet observational study may be in trouble. More...

May 28, 2020

C.COOL

RE:Cannabis Reality

helpline88 wrote: Our local Vancouver Province Newspaper today reports that...

May 28, 2020

V.TLT

RE:Some movement in the patent office

Additional research out of CSU last month confirming anti-cancer potential of...

May 27, 2020

V.TLT

RE:Some movement in the patent office

Thanks Pandora...would be great to see TLT combine their PDT/ACT with a...

May 27, 2020